标签： Barbados

During an official working visit to Barbados, World Bank Group President Ajay Banga laid out a targeted policy roadmap for Small Island Developing States (SIDS) to accelerate inclusive, resilient economic progress, centred on cutting red tape, lowering financing costs, and de-risking investments to draw in far greater volumes of private capital. Banga delivered the remarks while touring a portfolio of World Bank-supported local development sites alongside Barbadian Prime Minister Mia Mottley and senior government leadership, including the Oceana Innovation Hub, Bridgetown Fisheries Complex, Kensington Oval, Six Men’s fishing village, and the National Botanical Gardens.

In his address to assembled reporters, Banga emphasised that streamlining regulatory frameworks to reduce unnecessary administrative friction – while retaining robust safeguards to protect public welfare – would immediately boost SIDS’ competitiveness as investment destinations. He used a tangible example to illustrate the gap: a hotel chain developer choosing between a jurisdiction that requires 30 separate permits to launch operations, and Barbados where only nine are mandated, would unhesitatingly direct its resources to the more efficient market. He clarified that regulatory streamlining is only the first step of a multi-pronged strategy, with complementary reforms required to bring down exorbitant borrowing costs for island economies and create structured risk-mitigation tools for external investors.

Banga detailed that the World Bank’s ongoing bilateral partnership with Barbados is tailored to support the country’s next growth phase, with coordinated work to optimise public spending efficiency, strengthen core government institutional systems, and catalyse expanded private sector participation. He confirmed that he and Prime Minister Mottley are in active advanced discussions on advancing climate-resilient infrastructure rollouts, overhauling public sector operational efficiency, and restructuring Barbados’ existing debt portfolio via targeted World Bank guarantees that can unlock far more favourable long-term financing terms. The cost savings generated from these restructured arrangements, Banga noted, will be channelled directly to high-priority public projects, including a new national geriatric hospital and a pipeline of climate-adaptive infrastructure upgrades.

The World Bank chief also highlighted the success of flexible disaster response clauses embedded in the institution’s loan agreements for vulnerable nations, a policy framework that was first shaped during his initial discussions with Mottley shortly after he assumed the World Bank presidency in June 2023. Under these provisions, SIDS can redirect up to 10% of unspent, pre-approved project funding to deliver emergency support to citizens immediately following a natural disaster, without navigating lengthy new approval processes. Banga noted that the intentionally broad, non-restrictive language of these clauses has already proven highly effective across a wide range of crisis scenarios, from earthquakes and flash floods to major hurricanes, avoiding narrow eligibility rules that would have blocked vulnerable countries from accessing critical rapid relief. He added that the policy is explicitly designed to centre national leadership, ensuring that response decisions are led by local governments rather than external institutional mandates.

Banga also shared updated institutional data showing that the World Bank successfully mobilised $112 billion in global private capital for emerging markets in the most recent fiscal year, on top of $120 billion deployed directly from the institution’s own balance sheet – a volume of private capital mobilisation that is 3 to 4 times higher than the totals recorded just three years prior.

For her part, Prime Minister Mottley outlined Barbados’ dual-track investment strategy, which aims to combine incoming foreign private capital with untapped local household savings to expand broad-based economic participation for all Barbadian citizens. She noted that roughly 16 billion Barbadian dollars (equivalent to $8 billion USD) is currently held in domestic bank accounts earning only 0.1% annual interest, and that the government is collaborating closely with the World Bank to design new accessible financial instruments that will allow ordinary Barbadians to invest small portions of their savings in national development projects, without requiring households to draw down all of their accumulated funds. Mottley acknowledged that while expanding local investment ownership is a core policy priority, domestic savings alone will not be sufficient to meet the country’s full long-term investment requirements, making targeted, responsible foreign capital inflows a critical complementary component of Barbados’ growth agenda.

A landmark $64 million pharmaceutical manufacturing facility in Christ Church, Barbados, is moving rapidly toward realization after two binding collaborative agreements were formalized at the recent Commonwealth Business Forum hosted in Antigua and Barbuda, marking a major milestone for the island’s industrial and public health infrastructure. Slated for development within the Grantley Adams Industrial Estate, the state-of-the-art plant will boast an annual production capacity of 12 million bags of intravenous (IV) fluids, designed first to meet local domestic demand before expanding distribution across Caribbean regional export markets. The core partnership driving the project brings together Barbadian entity Barbados Pharmaceutical Inc. (BPI) and Nigeria’s AMA Medical Manufacturing, with the pair signing a formal memorandum of understanding (MoU) during the high-profile forum to codify their joint venture framework. The signing ceremony was overseen by key regional and national leaders, including Barbadian Prime Minister Mia Mottley and Nigeria’s Secretary to the Government of the Federation Senator George Akume, with BPI acting CEO Dr. Cindi Lewis and African Medicines Agency Chairman Abdullahi Musa Bello executing the official partnership paperwork. A complementary second agreement was also inked between AMA and the African Export-Import Bank (Afreximbank), unlocking dedicated technical support and structured financial planning resources to shepherd the project through pre-investment due diligence and preparatory phases. BPI leadership emphasized that the core mission of the new facility is to slash the Caribbean’s longstanding overreliance on imported IV fluids, which has left regional healthcare systems vulnerable to global supply chain disruptions, while fortifying consistent access to life-saving essential medical supplies for local populations. The project is projected to create over 200 direct full-time jobs for Barbadians, with structured upskilling pathways to equip local workers with specialized, globally competitive expertise in pharmaceutical production, rigorous quality assurance protocols, and adjacent technical operational fields. Under the terms of the agreed joint venture, AMA will take the lead on end-to-end facility design, construction oversight, and day-to-day operational management once the plant is commissioned, while BPI will leverage its local networks to secure land tenure, navigate domestic pharmaceutical regulatory frameworks, streamline market entry across Caribbean jurisdictions, and sustain ongoing close engagement with the Barbadian government. This $64 million IV fluids facility is the first tangible output of a far broader national strategy to build a full-fledged domestic pharmaceutical manufacturing sector in Barbados, a vision first unveiled by Prime Minister Mottley back in November 2022 following high-level bilateral discussions with Rwandan government counterparts. At that initial announcement, Mottley projected the wider industry could generate between 4,000 and 5,000 skilled local jobs within a four to five year timeline, with long-term ambitions to expand production portfolios to include life-saving vaccines, targeted cancer therapies, and critical women’s reproductive health medications. Progress on that strategic vision accelerated in November 2023, when Barbados received a formal Biopharma White Book that mapped out the full regulatory and compliance groundwork required to bring the nation’s pharmaceutical sector in line with stringent international manufacturing standards. This foundational industry development initiative has been executed in close trilateral cooperation with Rwanda and Guyana, to align regional regulatory norms and create a unified cross-border market for locally produced medical supplies. The impetus for building domestic production capacity across the Caribbean was sharpened by widespread systemic failures witnessed during the COVID-19 pandemic, when nations across the region faced crippling delays and shortages of essential medicines, vaccines, and critical medical equipment even when they had allocated sufficient public funding to procure the supplies on global markets. The formal partnership with Nigeria took concrete shape in November 2025, when the two national governments signed a sweeping bilateral agreement covering cross-border pharmaceutical manufacturing collaboration, workforce skills development, coordinated regional and continental market access, and harmonized regulatory alignment. That intergovernmental pact built on months of prior exploratory discussions between Barbados and AMA Medical Manufacturing to establish a regional production hub on Barbadian soil. While the two newly signed agreements mark a critical inflection point for the IV fluids plant project, formal financing finalization and a slate of remaining pre-construction preparatory tasks will need to be completed before ground can be broken on the new industrial facility.